- Home
- BTAI vs STEC Comparison
BTAI vs STEC Comparison
Compare BTAI & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- STEC
- Stock Information
- Founded
- BTAI 2017
- STEC 2006
- Country
- BTAI United States
- STEC China
- Employees
- BTAI N/A
- STEC N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- STEC
- Sector
- BTAI Health Care
- STEC
- Exchange
- BTAI Nasdaq
- STEC NYSE
- Market Cap
- BTAI 28.7M
- STEC 31.4M
- IPO Year
- BTAI 2018
- STEC 2021
- Fundamental
- Price
- BTAI $0.57
- STEC $1.12
- Analyst Decision
- BTAI Strong Buy
- STEC
- Analyst Count
- BTAI 4
- STEC 0
- Target Price
- BTAI $5.00
- STEC N/A
- AVG Volume (30 Days)
- BTAI 458.6K
- STEC 2.4M
- Earning Date
- BTAI 11-14-2024
- STEC 11-26-2024
- Dividend Yield
- BTAI N/A
- STEC N/A
- EPS Growth
- BTAI N/A
- STEC N/A
- EPS
- BTAI N/A
- STEC N/A
- Revenue
- BTAI $2,276,000.00
- STEC $260,474,693.00
- Revenue This Year
- BTAI $247.03
- STEC $9.76
- Revenue Next Year
- BTAI $88.16
- STEC $15.85
- P/E Ratio
- BTAI N/A
- STEC N/A
- Revenue Growth
- BTAI 83.25
- STEC N/A
- 52 Week Low
- BTAI $0.50
- STEC $0.20
- 52 Week High
- BTAI $4.32
- STEC $7.31
- Technical
- Relative Strength Index (RSI)
- BTAI 43.77
- STEC 51.23
- Support Level
- BTAI $0.50
- STEC $1.04
- Resistance Level
- BTAI $0.72
- STEC $1.24
- Average True Range (ATR)
- BTAI 0.08
- STEC 0.24
- MACD
- BTAI -0.01
- STEC -0.04
- Stochastic Oscillator
- BTAI 20.70
- STEC 27.36
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.